Carter Bruce L A
- SEC CIK
- 0001225503
No open-market purchases or sales filed in the past year.
Current role at each company
- ENTA Enanta Pharmaceuticals IncDirectoras of Mar 13, 2026
- MRTX Mirati Therapeutics, Inc.Directoras of Jan 23, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Carter Bruce L A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRTX Mirati Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 (view filing) | Aug 12 | 4 days | Carter Bruce L ADirector | SSale | −10.0K | $85.49 | −$854.9K | −62.4%6.02K after | 2 lots |
ENTA Enanta Pharmaceuticals Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 (view filing) | Mar 21 | 1 day | Carter Bruce L ADirector | SSale | −6.00K | $67.83 | −$407.0K | −100.0%0 after | 4 lots |